Switch Case Study: Alli Review Contrasts OTC, Rx Division Perspectives
This article was originally published in The Tan Sheet
Executive Summary
Every month, F-D-C Reports' Pharmaceutical Approvals Monthly dissects a new drug review by FDA. Using FDA's own review documents, including the discipline reviews, decision memos, meeting minutes, e-mails and other documents, the publication strives to illuminate the agency's decision-making process.